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ABSTRAK 
 
 
 
Latar Belakang  
Kebelakangan ini, penyakit pendarahan otak secara spontan telah muncul sebagai salah satu 
daripada jenis penyakit strok atau angin ahmar yang paling dashyat dan memudaratkan. Penyakit 
ini mampu menyebabkan maut sebanyak 45% dalam 30 hari selepas pendarahan otak. Lebih 
banyak penyiasatan makmal and bukti klinikal yang dijalankan dalam tiga dan empat dekad yang 
lalu telah membuktikan bahawa mekanisme keradangan atau ‘inflamasi’ yang kompleks 
bertangungjawab untuk kesan mudarat yang dialami pesakit yang mengidapi penyakit 
pendarahan otak secara spontan. Penanda-penanda biologi dan sel-sel yang terlibat dalam proses 
keradangan ini memainkan peranan penting dalam propogasi penyakit dan kesan kemudaratan 
kepada pesakit. Walau bagaimanapun, hubungan di antara penanda-penanda biologi dalam darah 
dengan kesan kemudaratan dalam pesakit-pesakit ini tidak dapat dikenalpasti dengan lebih 
terperinci and objektif. Hubungan diantara penanda-penanda biologi dan hasil pemulihan dan 
fungsi pesakit-pesakit ini tidak dapat ditentukan dengan kepastian. Justeru itu, penyelidikan ini 
bertujuan untuk memberi satu rangka dan bukti untuk mengaitkan paras penanda-penanda 
biologi seperti sel darah putih dan C-Reactive Protein (CRP) dalam penyakit pendarahan otak 
dan sekaligus mengkaji hubungan penanda-penanda biologi ini dengan tahap kemandirian 
pesakit pada 6 bulan selepas mengalami pendarahan otak. Penyelidikan ini juga bertujuan untuk 
membuktikan bahawa paras sel darah putih and CRP mampu digunakan sebagai satu alat untuk 
menentukan kadar fungsi atau kemudaratan dan kematian dalam pesakit-pesakit yang mnegalami 
pendarahan otak secara spontan.  
 
Kaedah Penyelidikan 
Penyelidikan ini dijalankan secara prospektif dalam tatacara kerelasi untuk mangkaji kaitan di 
antara paras sel darah putih dan paras CRP pada waktu kemasukan hospital dan pada jangka 
masa 72 jam selepas kemasukan ke hospital, dengan tahap kemandirian dan kadar kematian 
pesakit pada 6 bulan selepas mengalami pendarahan otak. Kajian ini dijalankan di Hospital 
Umum Sarawak (HUS) dimana terdapat perkhidmatan neurosurgeri dan perubatan neurologi. 
Kajian ini dijalankan selama 2 tahun , di antara April 2013 ke April 2015. Butir-Butir lain seperti 
umur pesakit, jantina, skor Glasgow Coma Scale (GCS), tekanan darah semasa kemasukan 
hospital and butiran mengenai penyakit-penyakit tidak berjangkit yang dihidapi oleh pesakit 
diambil and dicatat. Sampel darah diambil sebanyak 2 kali – iaitu semasa kemasukan pesakit ke 
hospital dan sekali lagi dalam pada 72 jam selepas kemasukan ke dalam wad. Setiap pesakit juga 
menjalani penyiasatan radiologi dan pengimejan dalam bentuk CT scan otak untuk 
mengenalpasti ciri-ciri berkaitan pendarahan otak ; yakni berkaitan lokasi pendarahan otak serta 
jumlah isipadu pendarahan tersebut. Pesakit-pesakit yang layak dipilih untuk mengambil 
bahagian dalam kajian ini setelah memenuhi semua syarat-syarat yang ditetapkan. Data yang 
diperolehi akan dianalisakan dengan mengunakan sistem perisian  “Statistical Package for Social 
Sciences (SPSS) for Windows”  versi 21.0. Setelah peaskit menjalani rawatan dan dibenarkan 
pulang ke rumah, mereka akan disaring dan diperiksa semula di Klinik Neurosurgeri semasa 
lawatan susulan. Skor ‘Glasgow Outcome Score (GOS)’ ditentukan kelak semasa lawatan 
susulan pesakit-pesakit ini.  
 
 
 
Keputusan     
Seramai 60 orang pesakit dipilih untuk mengambil bahagian dalam kajian ini. Jumlah pesakit 
yang terdiri daripada kumpula pesakit dengan tahap kemandirian yang memuaskan atau baik 
(GOS 4-5) adalah seramai 20 orang (33.3%) dan jumlah pesakit yang mengalmai tahap 
kemandirian yang buruk atau tidak memuaskan adalah seramai 27 orang (45%). Seramai 13 
orang pesakit meninggal dunia (GOS 1) dalam masa diantara kemasukan hospital dan 72 jam 
selepas kemasukan hospital. Daripada jumlah 60 ornang pesakit ini, kita mendapati seramai 16 
orang pesakit (26.7%) terdiri daripada golongan umur pada atau kurang daripada 50 tahun, dan 
seramai 44 orang pesakit (73.3% terdiri daripada golongan yang lebih tua daripada umur 50 
tahun. Kebanyakan pesakit didapati dimasukkan ke hospital dengan skor GCS 9/15 ke 11/15 
iaitu seramai 13 orang (21.7%) untuk setiap skor GCS  9/15, 10/15, 11/15. Seramai 5 pesakit 
(8.3%) sahaja didapati mempunyai skor GCS 14/15 semasa kemasukan hospital.  Dalam kajian 
ini, kami mendapati bahawa skor GCS semasa kemasukan hospital berkait rapat dengan tahap          
kemandirian dan kadar kematian pesakit pada 6 bulan selepas mengalami pendarahan otak 
(p<0.05). Jumlah isipadu dan saiz pendarahan otak juga berhubung rapat dan secara langsung 
mempengaruhi tahap kemandirian dan kadar kematian pada masa 6 bulan selepas pendarahan 
otak (p<0.05). Paras sel darah putih juga berhubung rapat dengan saiz dan isipadu pendarahan 
otak, yakni, pesakit yang mengalami pendarahan otak yang besar, mempunyai paras sel darah 
putih yang tinggi. Ciri-ciri seperti umur dan jantina didapati tidak berkaitan secara langsung 
dengan tahap kemandirian atau dengan kadar kematian pesakit-pesakit ini pada 6 bulan selepas 
pendarahan otak. Didapati juga paras sel darah putih dan CRP semasa kemasukan hospital dan 
pada 72 jam selepas kemasukan hospital mempunyai hubungan yang langsung dan jelas dalam 
meramalkan tahap kemandirian dan kadar kematian pesakit-pesakit ini6 bulan selepas 
mengalami pendarahan otak (p<0.05)     
 
 
Kesimpulan 
Secara kesimpulannya, kami mendapati bahawa unsur-unsur seperti skor GCS semasa 
kemasukan hospital, saiz pendarahan otak, paras sel darah putih dan CRP pada waktu kemasukan 
ke hospital dan pada 72 jam selepas kemasukan hospital, secara langsung dapat meramalkan 
tahap kemandirian dan kadar kematian pesakit-pesakit yang mengalami pendarahan otak secara 
spontan.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
 
Background 
Spontaneous IntraCerebral Hemorrhage (SICH) has emerged as one of the most devastating 
forms of stroke in recent decades. This disease is noted to carry a 30 day mortality rate of 
approximately 45%.  An increasing number of studies have implicated a complex immune-
mediated and inflammation mediated cascade of responses in the pathophysiology of SICH and 
the resultant neurologic outcome. Several clinical studies have demonstrated an association 
between inflammatory markers and outcome in patients with SICH. However, the exact 
relationship between serum biomarkers and functional outcomes amongst survivors has not been 
clearly elucidated . This study aims at providing a promising perspective and to evaluate the 
changes in peripheral leukocyte count (WBC count) and C-Reactive Protein (CRP) level in 
patients with SICH and to correlate these findings with survival and functional outcome, thus to   
to support and substantiate existing evidences.   
 
Methodology 
A prospective, descriptive and correlational study was conducted in Hospital Umum Sarawak 
(HUS) over the span of 2 years ( April 2013 till April 2015) . Patients with supratentorial 
intracerebral bleed secondary to uncontrolled hypertension, aged between 30-75 years were 
recruited in this study . Data pertaining to the demography ( age, gender, BP, GCS score, and  
 
 
co-morbidities) , clinical and radiological parameters (  site of lesion and the volume of the clot ) 
were collected on admission. Blood samples were taken to measure peripheral WBC count and 
CRP level on admission and at 72 hours of admission. Mortality and functional outcomes were 
determined at 6 months post ictus. Patients were recruited following fulfillment of exclusion and 
inclusion criteria and all obtained data was analyzed with Statistical Package for Social Sciences 
(SPSS) for Windows version 21.0.   
 
Results  
A total of 60 patients were recruited in this study. We found about 16 patients were less than or 
equal to 50 years old (26.7%) and 44 patients belong to the older age group of above 50 years 
(73.3%). Majority of patients presented with GCS score of 9/15 to 11/15 with a total of 13 
patients (21.7%) in each group of  9/15, 10/15 and 11/15. The least number of patients 
encountered belonged to the GCS score of 14/15 – a total of 5 patients (8.3%). GCS score on 
admission was noted to be significantly related to 6 month functional outcome or Glasgow 
Outcome Scale (GOS) and overall mortality or survival (p<0.05).  The morbidity and overall 
mortality or survival was also found to be significantly associated with volume of clot at 
presentation (p<0.05). WBC count was also noted to be correlating with haematoma volume at 
admission – patients with large haematoma volume inevitably had elevated WBC count. Age and 
gender was not found to be significantly related to the survival or 6 months functional outcome 
(p>0.05). WBC count and CRP level on admission and at 72 hours of admission noted to have 
relationship with overall 6 months GOS or functionality and also with overall survival (p<0.05). 
Total number of patients belonging to the better Glasgow Outcome Score (GOS) group (GOS 4-
5) was found to comprise 20  patients (33.3%) and about 27 patients (45%)  belonged to the poor 
GOS group (GOS 2-3) . About 13 patients (21.7%) succumbed to the disease (GOS 1).    
 
Conclusion  
We could conclude that via this study, it was evident that in patients with SICH, the main 
determinants or predictors of functional outcome at 6 months and overall survival were noted to 
be GCS score on admission, clot size, WBC count and CRP levels on admission and at 72 hours 
of admission.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1 
 
Introduction 
Spontaneous IntraCerebral Hemorrhage (SICH) has emerged as one of the most 
devastating subtype of stroke. Epidemiologically, SICH is a leading cause of morbidity and 
mortality worldwide (Broderick JP et al., 2007). It has been proven to pose worse outcomes than 
ischemic stroke (Gere J et al., 2003), and is increasing in prevalence currently owing to the 
advancement in primary care – both in clinically and radiologically ; as more and more of these 
cases are detected and treated early . It has a 30 day mortality of 40-50% (Roger VL et al., 2011; 
Van Asch CJ et al., 2010). Despite the knowledge of the pathophysiology and acute treatment of 
stroke has advanced by leaps and bounds in the past decade, progress observed with SICH has 
been much slow-paced and phlegmatic (Mayer and Rincon, 2005; Qureshi et al., 2009). The 
burden of a long term disability and poor outcome in  SICH are still deemed high, with only < 
40% of patients becoming independent at 1 year (Van Asch CJ et al., 2010) despite the fact that 
there has been advances in management and clinical knowledge in recent times.   
 
Causative factors of SICH are classified into as either primary – which are causes 
unrelated to congenital or acquired lesions) or secondary – which are attributed to congenital or 
acquired lesions. Primary SICH accounts for 78% to 88% of cases and originates from the 
spontaneous rupture of small arteries or arterioles damaged by two major causes: hypertensive 
arteriolosclerosis and amyloid angiopathy (Mayer and Rincon, 2005; Qureshi et al., 2001; 
Sutherland and Auer, 2006). Ariesen MJ et al., 2003 identified hypertension as the most 
significant modifiable risk factor, occurring in 50-70% of patients. On the other hand, secondary 
SICH is caused by identifiable lesions in brain such as tumour, aneurysms and vascular 
anomalies. Secondary SICH is also increasingly found to be related to the use of anti-coagulant 
or coagulopathic states, and thrombolytic treatment of ischemic stroke (Mayer SA et al., 2005; 
Qureshi AI et al., 2001; Sutherland GR et al., 2006 ; Wang J et al., 2005). In all SICH cases, the 
extravasated blood accumulates and compresses the surrounding brain parenchyma tissue. The 
commonest location of SICH are ganglionic (putamen, caudate nucleus and thalamus), followed 
by lobar, cerebellar and pontine or brainstem. In this study, we have only examined and recruited 
patients presenting with primary supratentorial SICH (bleeding in the region of putamen, caudate 
nucleus or cortical lobar) due to hypertension. Mainstay goal of treatment for SICH is merely 
supportive, and the anticipated long term clinical outcome is generally poor and the potential 
extensive burden for the primary caretakers is ubiquitous. 
 
It is imperative at this juncture that we would like to stress that to improve the clinical 
outcome of patient with SICH, a sound understanding of the pathophysiology of SICH induced 
brain injury is of paramount importance. Recently there has been more than compelling 
evidences to suggest that robust inflammatory mechanisms are triggered in SICH induced brain 
injury (Aronowski J et al.,2005 ; Wang J et al.,2005).  
Loftspring MC et al. in 2010 , found that in animal models, a robust inflammatory response is 
activated by the entry of blood into the brain parenchyma with a consequent infiltration of 
peripheral leukocyte or White Blood Cells (WBC), activation of microglia and release of 
cytokines. This findings were further reciprocated in other studies (Xi G et al.,2006 ; Wang J et 
al.,2007). Autopsies conducted in both animals (Gong C et al.,2000) and in human subjects 
(Mackenzie JM et al.,1998) with SICH found leukocytic infiltration usually occurs within the 
first 3 days of insult and a further cascadial inflammatory changes in the penumbra of the 
hemorrhage following SICH comes into play in the natural history of the disease. In the past, 
very few clinical studies have demonstrated an association between the inflammatory markers 
and outcomes of SICH in terms of mortality (Di Napoli M et al.,2011). Another inflammatory 
biomarker that has sparked a recent interest in the research of neuro-inflammation related to 
SICH is C-Reactive Protein (CRP). Di Napoli M et al. in 2011 discovered that elevated levels of 
CRP, an acute-phase reactant induced by IL-6, is directly associated with 30-day mortality in 
SICH patients.  
 
 To our knowledge, very few studies evaluated the functional or long term outcomes in 
SICH in relation to WBC and CRP levels. Several prospective studies in ischemic stroke patients 
have reported that increased levels of acute inflammatory markers, such C-reactive protein 
(CRP) (Jennifer G et al.,2009 ; Di Napoli M et al.,2011) and white blood cell (WBC) count 
(Wang J et al.,2007) are associated with increased risk of death or disability. The prognostic role 
of these inflammatory markers after SICH is ambiguous  (Diamond P et al.,2003 ; Flaherty ML 
et al.,2006).  In this study, we have evaluated the relationship between activation of the 
inflammatory response as measured by change in peripheral WBC count, and CRP levels – to 
mortality and functional outcomes after SICH.  
 
Currently existing data that was collected from both preclinical and clinical studies 
illustrates that inflammatory processes are involved in SICH (Aronowski J et al., 2005) and in 
the evolution of SICH induced brain injury (Wang J et al. 2007). Several prospective studies 
have been conducted implicated that brain injury secondary to a SICH is characterized by acute 
local inflammation (Wang J et al.,2007 ; Keep RF et al.,2005) and the elevated levels of 
inflammatory markers after SICH predict worse prognosis (Castellanos M et al.,2005) , 
perihematoma brain oedema (Castillo J et al.,2002), early neurological deterioration (Leira R et 
al.,2004), and early growth of SICH (Silva Y et al., 2005). Elevated WBC count has been 
proclaimed to be one of the independent predictors of early neurologic deterioration in SICH 
(Silva Y et al.,2005 ; Leira R et al.,2004) . As stressed earlier, CRP , another promising 
inflammatory biomarker, has been postulated to predict prognosis in patients presenting with 
SICH (Di Napoli M et al.,2005). These findings has catalyzed renewed interest in the study of 
neuro-inflammation related to SICH which includes the study of relation of SICH prognosis and 
outcome to CRP level and WBC count. Therefore, in this study the potency of WBC and CRP in 
determining the eventual outcome and mortality in SICH patients are investigated. The 
understanding of physiology of WBC and CRP is important before the realm of neuro-
inflammation related to SICH is explored and studied.  
 
 White blood cells (WBCs), also called leukocytes , are the ‘mobile units’ of the immune 
system responsible in  protecting the body against infectious disease. It is the first line defense 
against non-bodily foreign invaders and catalyzes the chain of events that brings about 
inflammation.  All leukocytes are produced and derived from a pluripotential haematopoietic 
stem cell in the bone marrow. There are 6 different and diverse types of leukocytes identified  – 
namely the neutrophils, eosinophils, basophils, lymphocytes, monocytes and occasional 
plasma cells (Ford-Hutchinson A et al.,1985) These types are distinguished by their physical and 
functional characteristics. The number of leukocytes in the blood is often a reliable indicator 
of disease (Feuerstein G et al.,1987) The normal WBC count is usually between 4 and 11 × 109/L 
and they make up approximately 1% of the total blood volume in an adult. 
 
Neutrophils constitute the most in total WBC count which is about 60-70% of the 
circulating leukocytes (Bruce Alberts et al.,2002) . Neutrophils defend against bacterial or 
fungal infection and are usually first responders to microbial infection. They are commonly 
referred to as polymorphonuclear (PMN) leukocytes. They have a multi-lobed nucleus, which 
consists of three to five lobes connected by slender strands (Saladin and Kenneth 2012) and this 
gives the neutrophils the appearance of having multiple nuclei, hence the name 
polymorphonuclear leukocyte. Neutrophils are mature cells as compared to monocytes, that can 
attack and destroy bacteria even in circulating blood. Average life span of a circulating human 
neutrophil is about 5.4 days (Pillay J et al 2010).   
 
Eosinophils comprise about 2-3% of the total WBC. Eosinophils are weak phagocytes 
and their counts fluctuates throughout the day, seasonally, and during menstruation. Eosinophils 
have a propensity to rise in response to allergies, parasitic infections, collagen diseases, and 
disease of the spleen and central nervous system. They are found in abundance in the mucous 
membranes of the respiratory, digestive, and lower urinary tracts (Saladin and Kenneth 2012). 
They primarily deal with parasitic infections and are also the key role player as the predominant 
inflammatory cells in allergic reactions. The most important causes of eosinophilia include 
allergies such as asthma, hay fever, and hives; and also parasitic infections. Although most of the 
parasites are too large to be phagocytized by eosinophils, they secrete chemicals that destroy 
these large parasites, such as hook worms and tapeworms, that are too big for any one WBC to 
phagocytize (Howard J etal.,1984) 
 
Basophils are chiefly responsible for allergic and antigen response. Because they are the 
rarest of the white blood cells (less than 0.5% of the total count) and share physico- chemical 
properties with other blood cells, they are difficult to study ( Falcone and Franco 2000) They 
excrete two chemicals that aid in the body's defenses: histamine and heparin. Histamine plays an 
exceedingly important role for widening blood vessels which in turn increases the flow of blood 
to injured tissue. It also promotes increased permeability of blood vessels to enable neutrophils 
and clotting proteins to get into connective tissue more easily. Heparin is an anticoagulant that 
inhibits blood clotting and promotes the movement of white blood cells into an area. Basophils 
can also release chemical signals that attract eosinophils and neutrophils to an infection site. 
 
  Lymphocytes are much more common in the lymphatic system than in blood. They play a 
pivotal role in body’s acquired immunity (Beer J et al.,1984). Lymphocytes include: 
• B cells – provides body with humoral immunity which make antibodies that can bind 
to pathogens, block pathogen invasion, activate the complement system, and enhance 
pathogen destruction. 
• T cells – provides body with cell mediated immunity. Several types identified : 
• CD4+ helper T cells 
• CD8+ cytotoxic T cells:  
• γδ T cells  
• Natural killer cells -  role is implicated in destruction of cells of the body that do not 
display MHC class I molecules, or display stress markers such as MHC class I 
polypeptide-related sequence A (MIC-A). A decreased expression of MHC class I and 
up-regulation of MIC-A can happen when cells are infected by a virus or become 
cancerous (Heberman R et al.,1987) 
 
Monocytes share the phagocytosis function of neutrophils, but are much longer lived as 
they have an extra role: they present pieces of pathogens to T cells so that the pathogens may be 
recognized again and killed. This causes an antibody response to be mounted. Monocytes 
eventually leave the bloodstream and differentiate into mobile  tissue macrophages 
 
 
 
                  Figure 1 :  Diagram showing the source of WBC 
 Figure 2  :  Diagram illustrating the formation and differentiation of WBC  
 
  
Another inflammatory biomarker implicated in this study is CRP. C- reactive protein 
(CRP) was discovered by Tillett and Francis in 1930 (Tillet WS et al. 1930). They first 
discovered it as a substance in the serum of patients with acute inflammation that reacted with 
the C- (capsular) polysaccharide of pneumococcus (Tillet WS et al 1930) . CRP was initially 
postulated as a pathogenic secretion as it was elevated in people with a variety of illnesses 
including cancer (Pepys et al. 2003). However, the discovery of the hepatic synthesis of CRP by 
Peter J Kennelly et al. in 2007 demonstrated that it is a native protein. This finding was further 
reinforced by research conducted by  Matthew R et al. in 2007.  CRP is produced mostly by liver 
hepatocytes in response to cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor 
necrosis factor (TNF)  (Butterweck V et al.,2003) which are triggered in acute inflammation.  
 
  CRP is a highly conserved trace protein found in the circulation of even healthy subjects, 
with a median concentration of approximately 1 mg/L(<5mg/L) . As the quintessential member 
of the acute phase proteins its concentration could increase upto  100-fold or more in response to 
injury, infection, or inflammation ( Erren M et al.,1999). Sometimes, acute phase phenomena 
may also accompany chronic inflammatory disorders. Moderately increased plasma CRP 
concentrations are found in smokers and under conditions of atherosclerosis, hypertension, 
psychological stress, diabetes, and in the elderly (Cao JJ et al.,2003) These levels are however 
not significantly elevated . Any levels above 5mg/L should raise the suspicion of an ongoing or 
underlying inflammatory process (Pepys MB et al.,2003). As CRP is a molecule that acts via 
pattern recognition , it binds to specific molecular configurations that are typically exposed 
during cell death or found on the surfaces of pathogens. John J et al. in 2008 concluded that rapid 
increase in CRP levels within hours following tissue injury or infection suggests that it 
contributes to host defense or innate immune response.  CRP is also found to be able to interact 
with DNA and histones and in turn may scavenge nuclear material released from damaged 
circulating cells (Wolford JK et al. 2003). 
The CRP cytogenetic band is located on the first chromosome - 1q21-q23.  Wolford JK et 
al. in 2003 also discovered that it has  a 224-residue protein with a monomer molar mass of 
25106 Da and the assumes an annular pentameric disc shape.  
 
 Figure 3   Pentameric structure of CRP viewed down the 5-fold symmetry axis.  
 
CRP assay and analysis could be done via various analytical methods.  One such method 
is done by collecting the blood in a serum-separating tube and is analyzed in a medical 
laboratory via  ELISA (Enzyme-Linked Immunosorbent Assay). This technique essentially 
requires any ligating reagent that can be immobilized on the solid phase along with a detection 
reagent that will bind specifically and use an enzyme to generate a signal that can be properly 
quantified (Thompson D et al.,1999).  
 
Conventionally, there are two different tests for CRP. The standard CRP test determines 
CRP levels over a much wider range and is deemed less sensitive in the lower ranges. On the 
other hand, the high-sensitivity CRP (hs-CRP) test can more accurately and rigorously detect 
lower concentrations of the protein. It is proven that estimating the levels of hs-CRP is more 
useful than the standard CRP test in predicting a healthy person's risk for cardiovascular related 
diseases (Clyne B et al.,1999). In this study, we have measured the standard CRP levels in 
patients as the cost of measuring the levels of hs-CRP is not economically feasible.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1    Background 
 Rosamond W et al. in 2007 concluded that Spontaneous IntraCerebral Haemorrhage 
(SICH) accounts for 8% to 14% of all strokes and carries the highest mortality rate among the 
major stroke subtypes . Current available pharmacological and surgical interventions are less 
efficient than in case of ischaemic stroke (Steiner T et al.,2014). Approximately half of the 
mortality occurs within the first 2 days as a result of brain herniation (Broderick JP et al.,1999). 
SICH is estimated to occur in about 70,000 people a year in the United States (Morgenstern LB 
et al.,2010). It accounts for 20-30% of all type of stokes in Asian countries (Quereshi AI et 
al.,2009). SICH was noted to be occurring more common in men, in elderly people and of Asian 
and African American descent (Sacco RL et al.,1994).  
 
The most important risk factor for ICH is identified as age. A 2 fold increase in incidence 
is observed in aach advancing decade from 50-80 years. The incidence of SICH increases with 
age and the average risk doubles for every 10 years after the age of 35 (Broderick et al.,1999). 
Other identifiable significant risk factor is hypertension is the most significant modifiable risk 
factor, occurring in 50-70% of patients (Arlesen MJ et al.,2003). Non modifiable risk factors 
were gender (male sex) and age. Other modifiable risk factors attributed to SICH are diabetes 
mellitus (Juvela et al.,1996), smoking (Thrift et al.,1998), dyslipidaemia (Sturgeon et al.,2007) 
and large quantity of alcohol intake (Ariesen et al.,2003). Hypertension is mainly associated with 
deep cerebral, ganglionic, lobar, cerebellum and brainstem locations ( Flaherty ML et al.,2006) 
Hypertension was identified as most prevalent modifiable risk factor in SICH accounting for 
about 60-70% of all cases (Brott et al.,1986) . The presence of apolipoprotein E2 and E4 alleles 
in patients was also found to be related to increase in incidence of vascular amyloid deposition 
which in turn may result in lobar SICH (Woo et al.,2005).  
 
The identified common causes of SICH was hypertension which accounts for about 60-
70% of the cases (Brott et al.,1986). Chronic hypertension causes degeneration, fragmentation 
and fibrinoid necrosis of small perforating arteries which would be later prone for rupture in case 
of elevated BP (Fischer et al.,1971), Cerebral amyloid angiopathy accounts for the 2nd most 
common cause for SICH (Qureshi AI et al.,2001). Other secondary causes of SICH include 
vascular malformations, tumour, haemorrhagic transformation of infarct, anti-coagulants, and 
cerebral venous thrombosis (Manno et al.2005) 
 
2.2    Pathophysiology of SICH and the role of neuro-inflammation  
The primary brain injury after SICH is mainly caused by the complex dynamic formation 
of the blood clot which damages and disrupts the surrounding tissue. This causes a mechanical 
damage associated with the clot mass and it in turn will exert a mass effect.damage associated 
with the mass effect (Xi G et al.,2010). Besides treating increased intracranial pressure 
(Helboketal et al., 2011), surgical interventions to remove the blood clot and immediately 
decompress the mounting pressure is the mainstay of treatment. (Gautschi and Schaller et 
al.,2013). However, in about one third of patients (Kazuietal et al.,1996; Brottetal et al.,1997), 
re-bleeding may occur and resulting in the expansion of the hemorrhage within the first day 
following insult. This in turn will further worsened the mass effect and thus causing further 
deterioration of neurological status. Main strategy in preventing this complication is by 
aggressive antihypertensive therapy or by administration of hemostatic factors may prevent 
secondary hematoma growth.(Sakamoto et al.,2013).. Breakdown of blood brain barrier is also 
attributed to early expansion of SICH (Olson et al.,1993) . 
 
Secondary brain injury after SICH may be caused by a cascade of events initiated by the 
primary injury which triggers the body/tissue response to the haematoma or the aseptic 
inflammation. The release of clot components like haemoglobin and iron may trigger a multi-
tiered cascade of inflammatory responses and liberation of inflammatory and chemical mediators 
. Thrombin release is an important initial tissue response to SICH which activates the 
haemostatic mechanisms to curb the initial bleeding. Thrombin plays a central role in that 
haemostasis. However, there is also much evidence that thrombin can participate in ICH-induced 
injury. Thrombin formation may cause neuro-toxicity and cause inflammatory cell infiltration, 
mesenchymal cell proliferation, scar formation, brain oedema formation and seizures., leading to 
disruption of blood-brain-barrier (Xi G et al.,2003). Liberated thrombin also is found to induce 
apoptosis in cultured neurons 
and astrocytes (Donovan FM et al.,1997) . Liu DZ et al. in 2011 found that thrombin also   
contributes to mitogenic stress, excitoxicity, vascular hyperpermeability and inflammation. 
Studies have shown that thrombin inhibition can reduce ICH induced injury (Xi G et al. 2003). 
However, it is imperative to highlight that while high concentrations of thrombin may mediate 
ICH-induced brain injury, low concentrations are neuroprotective.(Vaughan PJ et al.,1995) and 
is involved in brain recovery and neurogenesis (Yang S et al.,2008) 
 
 More and more clinical trials have compiled evidences that suggest inflammatory 
mechanisms are involved in the progression of ICH induced brain injury. These inflammation 
was mediated by molecular components like progtaglandins, chemokines, cytokines (Tumour 
necrosis factor (TNF), Interleukins (IL) 1 and 6), complement system, extracellular proteases and 
reactive oxygen species (Wang J et al.,2007). The are also cellular mediated response induced 
injury brought upon by leukocytes and microglia.  
 
2.3    Measurement of ICB volume  
It is exceedingly evident now that volume of intracerebral hemorrhage is the strongest 
predictor of 30-day outcome for all locations of spontaneous intracerebral hemorrhage (Hanel et 
al.,2002). Commonly used method for estimation of volume of the clot is via Kothari’s method 
(AxBxC/2) (Kothari RU et al.,1996). For the purpose of prognosis, a model of 30-day mortality 
that used the Glasgow Coma Scale (GCS) score and hemorrhage volume in patients with ICH 
correctly predicted outcome with a sensitivity and specificity of 97% (Broderick JP etal.,2003). 
This method of estimating ICH volume was even used in the for patient eligibility assessment in 
the multicenter Surgical Trial of IntraCerebral Hemorrhage (STICH trial)  (J. Grotta et al. 1996)  
 
 
 Figure 4 :  The estimation of volume for an ellipsoid object is 4/3 x π x A x B x C 
 
 
 
 
Figure 5  :     Calculation of the volume of the haematoma based on the volumetric  
                      formula for an ellipse. In this figure a,b, and c are the radius of the  
                      sphere; A,B and C are the diameters of the sphere; and  : 3.142 
 
 
 
CHAPTER 3 
 
STUDY PROCEDURE 
 
3.1 Problem statement 
 In recent years, it is been increasingly recognized that pathophysiology involved in 
spontaneous ICH is related to the patient’s immune response to the insult. As illustrated  in the 
study conducted by Wang J et al. in 2010, the infiltrating white blood cells (WBC) play a role in 
secondary injury after ICH. Preclinical studies have proven  that leukocytes are present 
surrounding the area of hematoma within hours after ICH (Zhao X et al.,2006). These 
neutrophils infiltrate the ICH first and may in turn catalyze a cascade of immune responses and 
cause direct detrimental effect or injury by releasing reactive oxygen species, inflammatory 
proteases and damage to the blood brain barrier.(Wang J et al.,2010 ; Dore S et al.,2007). 
Recently, elevated levels of CRP has also been implicated in poorer outcome in patients with 
SICH and plays a significant role in prediction of their prognosis (Godoy DA et al.,2010). 
Despite all available evidences, very few studies have examined the efficacy of WBC and CRP 
levels exclusively, as a tool to predict long term outcome and survival. If elevated peripheral 
leukocytes and other available inflammatory biomarkers such as CRP, are proven to be a direct 
causal factor to worse prognosis in SICH, it could lay the foundation and act as a catalyst to 
more studies and to more targeted researches in the field of neuro-immunogy, that may shed a 
brighter light and generate new treatments in ICH patients. The aim of this study is such – to 
further reinforce the notion that elevated WBC and CRP levels do dictate a worse prognosis or 
outcome in patients with SICH.  
  
3.2  Importance and Validity of Research 
 In this study, we aim to prove that elevated WBC and CRP levels could lead to worsened 
outcome and poor prognosis in patients presenting with SICH. It is our hope that the findings of 
this study would resonate with previous studies conducted by Di Napoli M et al. in 2011, where 
elevated CRP level was found to determine enlargement of haematoma and the consequent 
worsening of clinical outcome. Likewise this study would like to be in line with findings of 
research conducted by Wang J et al. in 2007 which implicated elevated WBC levels to worsened 
clinical outcome. We would like to remain optimistic that the supplemental evidence found in 
this study would generate  clinical interest especially in the local setting in the field of neuro-
immunology and also reinforce the understanding of the pathophysiology mechanisms involved 
in the natural history of SICH. At present, there has been no such study conducted in the local 
setting to examine the importance and relation of inflammatory biomarkers in the clinical 
pathology of SICH.  Therefore, with a prospective study design, we intended to examine the 
correlation between elevated WBC and CRP  with clinical outcome, in patients with SICH.    
 
3.3 General Objectives 
 The mainstay purpose of this study is to evaluate the changes in peripheral leukocyte 
count (WBC count) and C-Reactive Protein (CRP) levels on admission and at 72 hours of 
admission in patients with SICH and to correlate these findings with survival and functional 
outcome at 6 months.  
 
 3.4  Specific Objectives 
1. To  assess the general demographic characteristics of patients presenting with 
spontaneous intracerebral haemorrhage   
2. To determine the relationship of WBC count on admission and at 72 hours 
following admission , with overall 6 month survival  
3. To determine the relationship of CRP level on admission and at 72 hours 
following admission , with overall 6 month survival  
4. To determine the relationship of WBC count on admission and at 72 hours 
following admission , with 6 month clinical outcome based on Glasgow Outcome 
Score (GOS) 
5. To determine the relationship of CRP level on admission and at 72 hours 
following admission , with 6 month clinical outcome based on Glasgow Outcome 
Score (GOS) 
 
3.5  Research Questions 
1. What are the general demographic characteristics of patients presenting with SICH? 
2. Is there a significant relationship between WBC count on admission with 6 months 
survival?  
3. Is there a significant relationship between WBC count at 72 hours of admission with 6 
months survival?  
4. Is there a significant relationship between CRP level on admission with 6 months 
survival?  
5. Is there a significant relationship between CRP level at 72 hours of admission with 6 
months survival?  
6. Is there a significant relationship between WBC count on admission with 6 months 
outcome based on Glasgow Outcome Score (GOS)? 
7.  Is there a significant relationship between WBC count at 72 hours of admission with 6 
months outcome based on Glasgow Outcome Score (GOS)? 
8. Is there a significant relationship between CRP level on admission with 6 months 
outcome based on Glasgow Outcome Score (GOS)? 
9. Is there a significant relationship between CRP level at 72 hours of admission with 6 
months outcome based on Glasgow Outcome Score (GOS)? 
 
3.6  Research Hypothesis  
1. There is significant relationship between WBC count on admission with 6 month survival 
and clinical outcome based on Glasgow Outcome Score (GOS) 
2. There is significant relationship between WBC count at 72 hours following  admission 
with 6 month survival and clinical outcome based on Glasgow Outcome Score (GOS) 
3. There is significant relationship between CRP level on admission with 6 month survival 
and clinical outcome based on Glasgow Outcome Score (GOS) 
4. There is significant relationship between CRP level at 72 hours following  admission 
with 6 month survival and clinical outcome based on Glasgow Outcome Score (GOS) 
 
 
 
  
CHAPTER 4 
 
MATERIALS AND METHODS 
 
4.1 Research Design  
This is a prospective, descriptive and correlational study conducted in a single centre to 
determine the relationship between WBC count and CRP level with 6 months outcome and 
survival, in patients admitted under Hospital Umum Sarawak for spontaneous intracerebral 
haemorrhage. Patients will be either admitted under Department of Neurosurgery or Department 
of Internal Medicine at Hospital Umum Sarawak (HUS) for further management of the 
intracerebral haemorrhage. The study was approved by the Malaysian Medical Research and 
Ethics Committee (MREC). [ NMRR ID : 14-1711-21272 (IIR) ] 
 
4.2       Research Location and Duration 
This study was conducted in a single tertiary centre – Hospital Umum Sarawak (HUS). 
Patients who fulfill the inclusion and exclusion criterias will be selected and included in this 
study. The total study duration was over a span of 2 years , from April 2013 till April 2015. 
 
 
 
 
 4.3 Inclusion criteria 
 The following are the inclusion criteria needed to be fulfilled by each patient prior being 
recruited for the study : 
a) Any patients with spontaneous supratentorial intracerebral haemorrhage 
secondary to uncontrolled hypertension   
b) Age 30-75 years old 
c) Patients presenting with spontaneous intracerebral haemorrhage for the first time 
d) Glasgow Coma Scale (GCS) score on admission between 9-14 
e) Size of intracerebral haemorrhage ranging from 10 – 30 cm3 
 
4.4 Exclusion criteria 
 The following are the exclusion criteria for patients deemed not eligible to be included in 
the study. 
a) Glasgow Coma Scale (GCS) score of less than 9/15  
b) Patients presenting with spontaneous intracerebral haemorrhage other than due to 
hypertension  
c) Patients with infatentorial bleed, brainstem bleed or thalamic bleed  
d) Patients with incomplete study duration (minimum 6 months )  
e) Pregnancy 
f) Patients with culture positive infection on admission 
 
g) Patient with underlying renal disease, hepatic disease, cancer or chronic systemic 
autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus etc.  
h) Patients who were treated surgically  
i) Patient who has undergone recent surgery or had major trauma (<4 weeks prior to 
SICH) 
j) Patients with recurrent intracerebral haemorrhage 
k) Patients with intraventricular bleed  
l) Patients with recent ischemic heart disease event like myocardial infarction 
m) Patients with acute or chronic infections (<4 weeks prior to SICH) 
 
4.5  Method of research 
 In this prospective research, we aim to study the relationship between WBC count and 
CRP level on admission and at 72 hours, with patient’s 6 month functional outcome (based on 
Glasgow Outcome Scale) and 6 month survival. We prospectively recruited all consenting 
patients fulfilling the inclusion and exclusion criterias, admitted to Hospital Umum Sarawak 
(HUS), with a diagnosis of SICH within 24 hours after onset of the stroke. The case subject of 
SICH was defined as abrupt onset of spontaneous intracerebral bleeding which was confirmed by 
cranial CT scan. Consents were obtained through their family members or legal representatives. 
Patients fulfilling the inclusion and exclusion criteria underwent detailed screening protocol 
which consisted of complete medical history, full neurological examination, blood tests which 
included routine Full Blood Count (FBC), CRP, renal and liver function tests, coagulation 
profile, ElectroCardioGram (ECG) and Chest X-ray. Data related to the age, sex, and general 
demographics related to patient was collected. GCS score and haematoma volume on cranial CT 
was assessed. The estimation of the hematoma size and volume was calculated based on the 
Kothari’s method of  AxBxC/2 formula (as described earlier in Chapter 2). All routine 
biochemistry and hematology results were collected on admission and at 72 hours of admission 
.Blood that was collected for laboratory analysis was collected in  EDTA and plain tubes.  
Firstly, the blood was collected in an Ethylenediaminetetraacetic acid (EDTA) containing tube 
and was sent for WBC level assessment and the blood which was collected in plain tube was sent 
for CRP level estimation.  
 
WBC count was determined with an automated haematology analyzer (SYSMEX 
Haemato-analyzer) . CRP on the other hand, was determined via a qualitative method using latex 
agglutination technique – by using the AVITEX-CRP kit ( provided by OMEGA Diagnostics). 
The AVITEX-CRP latex particles are coated with antibodies 
to human CRP, as described by Singer et al. in 1957. When the latex suspension is mixed with 
serum containing elevated CRP levels on a slide, clear agglutination is seen within 2 minutes. 
Examine the test slide under a strong light source after 2 minutes. A positive result is indicated 
by the obvious agglutination of the latex, in a clear solution. A negative result is indicated by no 
change in the latex suspension on the test slide. AVITEX-CRP has a detection limit of 5 mg/l of 
CRP in the patient’s serum. Positive results will be obtained at a CRP serum concentration above 
5 mg/l and negative results will 
be obtained at 5 mg/l and below. After baseline WBC counts and CRP concentrations on 
admission were obtained , patient was subsequently admitted to the ward for further 
management. Laboratory personnel were blinded to clinical information and quality control was 
maintained.  
